135 related articles for article (PubMed ID: 17446259)
1. The connexin31 F137L mutant mouse as a model for the human skin disease erythrokeratodermia variabilis (EKV).
Schnichels M; Wörsdörfer P; Dobrowolski R; Markopoulos C; Kretz M; Schwarz G; Winterhager E; Willecke K
Hum Mol Genet; 2007 May; 16(10):1216-24. PubMed ID: 17446259
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis.
Plantard L; Huber M; Macari F; Meda P; Hohl D
Hum Mol Genet; 2003 Dec; 12(24):3287-94. PubMed ID: 14583444
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of two sequence variants of GJB3 (G12D and R32W) on the function of connexin 31 in vitro.
Rouan F; Lo CW; Fertala A; Wahl M; Jost M; Rodeck U; Uitto J; Richard G
Exp Dermatol; 2003 Apr; 12(2):191-7. PubMed ID: 12702148
[TBL] [Abstract][Full Text] [Related]
4. Intracellular distribution, assembly and effect of disease-associated connexin 31 mutants in HeLa cells.
He LQ; Liu Y; Cai F; Tan ZP; Pan Q; Liang DS; Long ZG; Wu LQ; Huang LQ; Dai HP; Xia K; Xia JH; Zhang ZH
Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):547-54. PubMed ID: 16077902
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.
Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J
J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis.
Macari F; Landau M; Cousin P; Mevorah B; Brenner S; Panizzon R; Schorderet DF; Hohl D; Huber M
Am J Hum Genet; 2000 Nov; 67(5):1296-301. PubMed ID: 11017804
[TBL] [Abstract][Full Text] [Related]
7. [Erythrokeratodermia variabilis (EKV)--a disorder due to altered epidermal expression of gap junction proteins].
Ständer S; Stadelmann A; Traub O; Traupe H; Metze D
J Dtsch Dermatol Ges; 2005 May; 3(5):354-8. PubMed ID: 16372802
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.
Richard G; Smith LE; Bailey RA; Itin P; Hohl D; Epstein EH; DiGiovanna JJ; Compton JG; Bale SJ
Nat Genet; 1998 Dec; 20(4):366-9. PubMed ID: 9843209
[TBL] [Abstract][Full Text] [Related]
9. A new, recurrent mutation of GJB3 (Cx31) in erythrokeratodermia variabilis.
Morley SM; White MI; Rogers M; Wasserman D; Ratajczak P; McLean WH; Richard G
Br J Dermatol; 2005 Jun; 152(6):1143-8. PubMed ID: 15948974
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism.
Tang C; Chen X; Chi J; Yang D; Liu S; Liu M; Pan Q; Fan J; Wang D; Zhang Z
Hum Mol Genet; 2015 Nov; 24(21):6054-65. PubMed ID: 26251042
[TBL] [Abstract][Full Text] [Related]
11. A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death.
Easton JA; Albuloushi AK; Kamps MAF; Brouns GHMR; Broers JLV; Coull BJ; Oji V; van Geel M; van Steensel MAM; Martin PE
Exp Dermatol; 2019 Oct; 28(10):1106-1113. PubMed ID: 29570224
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3.
Richard G; Brown N; Smith LE; Terrinoni A; Melino G; Mackie RM; Bale SJ; Uitto J
Hum Genet; 2000 Mar; 106(3):321-9. PubMed ID: 10798362
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Cx31 and Cx43 in Differentiation-Competent Rodent Keratinocytes.
Au A; Shao Q; White KK; Lucaciu SA; Esseltine JL; Barr K; Laird DW
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066499
[TBL] [Abstract][Full Text] [Related]
14. EKV mutant connexin 31 associated cell death is mediated by ER stress.
Tattersall D; Scott CA; Gray C; Zicha D; Kelsell DP
Hum Mol Genet; 2009 Dec; 18(24):4734-45. PubMed ID: 19755382
[TBL] [Abstract][Full Text] [Related]
15. Intracellular domains of mouse connexin26 and -30 affect diffusional and electrical properties of gap junction channels.
Manthey D; Banach K; Desplantez T; Lee CG; Kozak CA; Traub O; Weingart R; Willecke K
J Membr Biol; 2001 May; 181(2):137-48. PubMed ID: 11420600
[TBL] [Abstract][Full Text] [Related]
16. Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations.
Di WL; Monypenny J; Common JE; Kennedy CT; Holland KA; Leigh IM; Rugg EL; Zicha D; Kelsell DP
Hum Mol Genet; 2002 Aug; 11(17):2005-14. PubMed ID: 12165562
[TBL] [Abstract][Full Text] [Related]
17. The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron.
van Steensel MA; Oranje AP; van der Schroeff JG; Wagner A; van Geel M
Am J Med Genet A; 2009 Feb; 149A(4):657-61. PubMed ID: 19291775
[TBL] [Abstract][Full Text] [Related]
18. Human connexin31.9, unlike its orthologous protein connexin30.2 in the mouse, is not detectable in the human cardiac conduction system.
Kreuzberg MM; Liebermann M; Segschneider S; Dobrowolski R; Dobrzynski H; Kaba R; Rowlinson G; Dupont E; Severs NJ; Willecke K
J Mol Cell Cardiol; 2009 Apr; 46(4):553-9. PubMed ID: 19168070
[TBL] [Abstract][Full Text] [Related]
19. A mutation in GJB3 is associated with recessive erythrokeratodermia variabilis (EKV) and leads to defective trafficking of the connexin 31 protein.
Gottfried I; Landau M; Glaser F; Di WL; Ophir J; Mevorah B; Ben-Tal N; Kelsell DP; Avraham KB
Hum Mol Genet; 2002 May; 11(11):1311-6. PubMed ID: 12019212
[TBL] [Abstract][Full Text] [Related]
20. Expression of a connexin31 mutation causing erythrokeratodermia variabilis is lethal for HeLa cells.
Diestel S; Richard G; Döring B; Traub O
Biochem Biophys Res Commun; 2002 Aug; 296(3):721-8. PubMed ID: 12176042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
